Association of Host Genetics With Vaccine Efficacy, and Evaluation of Immune Correlates of Risk From the First Proof of Concept Efficacy Study With a Tetravalent Dengue Vaccine
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2017
At a glance
- Drugs CYD TDV (Primary)
- Indications Dengue
- Focus Pharmacodynamics; Proof of concept
- Sponsors sanofi pasteur
- 28 Jun 2017 Status changed from active, no longer recruiting to completed.
- 25 Apr 2017 Planned End Date changed from 1 Jul 2017 to 1 Jan 2018.
- 25 Apr 2017 Status changed from recruiting to active, no longer recruiting.